Clinical Trial Update: Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating pembrolizumab with stereotactic body radiotherapy for advanced solid tumors; trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Chicago | Conditions: Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING